Zusammenfassung
Autismusspektrumstörungen („autism spectrum disorders“, ASD) gelten in den beiden aktuellen Klassifikationssystemen (ICD-10 und DSM-IV-TR) als Ausschlusskriterium für die Diagnose einer Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung (ADHS). Unaufmerksamkeit, Impulsivität und Hypermotorik gehören aber zu den häufigsten Begleitsymptomen der ASD. Psychopathologische, neuropsychologische, bildgebende und genetische Untersuchungen weisen auf mögliche pathophysiologische Zusammenhänge von autistischen Störungen und ADHS hin. Bei der Diagnostik beider Störungen sollte daher grundsätzlich geprüft werden, ob auch Symptome der anderen Störungen vorliegen. Die Behandlung der ADHS-Symptome bei Autismus gleicht zwar prinzipiell der Therapie nichtautistischer Kinder mit ADHS. Allerdings sind oft niedrigere Dosierungen und eine langsamere Titration empfehlenswert.
Summary
Exclusion criteria of the DSM-IV-TR and ICD-10 do prevent dual diagnoses of attention deficit hyperactivity disorder (ADHD) and autism spectrum disorders (ASD). However, inattention, impulsivity and hyperactivity are amongst the most frequent associated symptoms of ASD. Psychopathological, neuropsychological, brain imaging and genetic studies suggest possible pathophysiological links between ASD and ADHD. Thus, standard diagnostic procedures for both disorders should assess the presence of potential comorbid symptoms of the other disorder. Treatment strategies for ADHD symptoms in the context of ASD overlap with those for patients with ADHD, but lower dosages and slower titration might be recommendable.
Literatur
Albrecht B, Brandeis D, Uebel H et al (2008) Action monitoring in boys with attention-deficit/hyperactivity disorder, their nonaffected siblings, and normal control subjects: evidence for an endophenotype. Biol Psychiatry 64:615–625
Arnold LE, Aman MG, Cook AM et al (2006) Atomoxetine for hyperactivity in autism spectrum disorders: placebo-controlled crossover pilot trial. J Am Acad Child Adolesc Psychiatry 45:1196–1205
Asherson P, Zhou K, Anney RJ et al (2008) A high-density SNP linkage scan with 142 combined subtype ADHD sib pairs identifies linkage regions on chromosomes 9 and 16. Mol Psychiatry 13:514–521
Banaschewski T, Becker K, Scherag S et al (2010) Molecular genetics of attention-deficit/hyperactivity disorder: an overview. Eur Child Adolesc Psychiatry 19:237–257
Banaschewski T, Brandeis D (2007) Annotation: what electrical brain activity tells us about brain function that other techniques cannot tell us – a child psychiatric perspective. J Child Psychol Psychiatry 48:415–435
Banaschewski T, Brandeis D, Heinrich H et al (2004) Questioning inhibitory control as the specific deficit of ADHD – evidence from brain electrical activity. J Neural Transm 111:841–864
Banaschewski T, Coghill D, Santosh P et al (2006) Long-acting medications for the hyperkinetic disorders. A systematic review and European treatment guideline. Eur Child Adolesc Psychiatry 15:476–495
Banaschewski T, Hollis C, Oosterlaan J et al (2005) Towards an understanding of unique and shared pathways in the psychopathophysiology of ADHD. Dev Sci 8:132–140
Becker A, Woerner W, Hasselhorn M et al (2004) Validation of the parent and teacher SDQ in a clinical sample. Eur Child Adolesc Psychiatry 13(Suppl 2):11–16
Bölte S, Westerwald E, Holtmann M et al (2011) Autistic traits and autism spectrum disorders: the clinical validity of two measures presuming a continuum of social communication skills. J Autism Dev Disord 41:66–72
Brieber S, Neufang S, Bruning N et al (2007) Structural brain abnormalities in adolescents with autism spectrum disorder and patients with attention deficit/hyperactivity disorder. J Child Psychol Psychiatry 48:1251–1258
Bush G, Valera EM, Seidman LJ (2005) Functional neuroimaging of attention-deficit/hyperactivity disorder: a review and suggested future directions. Biol Psychiatry 57:1273–1284
Castellanos FX, Lee PP, Sharp W et al (2002) Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder. JAMA 288:1740–1748
Corbett B, Glidden H (2000) Processing affective stimuli in children with attention-deficit hyperactivity disorder. Child Neuropsychol 6:144–155
Corbett BA, Constantine LJ, Hendren R et al (2009) Examining executive functioning in children with autism spectrum disorder, attention deficit hyperactivity disorder and typical development. Psychiatry Res 166:210–222
Courchesne E, Pierce K (2005) Why the frontal cortex in autism might be talking only to itself: local over-connectivity but long-distance disconnection. Curr Opin Neurobiol 15:225–230
Courchesne E, Redcay E, Morgan JT et al (2005) Autism at the beginning: microstructural and growth abnormalities underlying the cognitive and behavioral phenotype of autism. Dev Psychopathol 17:577–597
Demurie E, Roeyers H, Baeyens D et al (2011) Common alterations in sensitivity to type but not amount of reward in ADHD and autism spectrum disorders. J Child Psychol Psychiatry
Elia J, Gai X, Xie HM et al (2010) Rare structural variants found in attention-deficit hyperactivity disorder are preferentially associated with neurodevelopmental genes. Mol Psychiatry 15:637–646
Faraone SV, Perlis RH, Doyle AE et al (2005) Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry 57:1313–1323
Fisher SE, Francks C, Mccracken JT et al (2002) A genomewide scan for loci involved in attention-deficit/hyperactivity disorder. Am J Hum Genet 70:1183–1196
Franke B, Neale BM, Faraone SV (2009) Genome-wide association studies in ADHD. Hum Genet 126:13–50
Freitag CM (2007) The genetics of autistic disorders and its clinical relevance: a review of the literature. Mol Psychiatry 12:2–22
Gadow KD, Devincent CJ, Pomeroy J (2006) ADHD symptom subtypes in children with pervasive developmental disorder. J Autism Dev Disord 36:271–283
Geurts HM, Corbett B, Solomon M (2009) The paradox of cognitive flexibility in autism. Trends Cogn Sci 13:74–82
Geurts HM, Verte S, Oosterlaan J et al (2004) Can the Children’s Communication Checklist differentiate between children with autism, children with ADHD, and normal controls? J Child Psychol Psychiatry 45:1437–1453
Geurts HM, Verte S, Oosterlaan J et al (2004) How specific are executive functioning deficits in attention deficit hyperactivity disorder and autism? J Child Psychol Psychiatry 45:836–854
Gillberg C (2003) Deficits in attention, motor control, and perception: a brief review. Arch Dis Child 88:904–910
Graham J, Banaschewski T, Buitelaar J et al (2011) European guidelines on managing adverse effects of medication for ADHD. Eur Child Adolesc Psychiatry 20:17–37
Grzadzinski R, Di Martino A, Brady E et al (2010) Examining autistic traits in children with ADHD: does the autism spectrum extend to ADHD? J Autism Dev Disord (in press)
Herbrecht E, Bölte S, Poustka F (2008) Frankfurter Kommunikations- und soziales Interaktions-Gruppentraining bei Autismus-Spektrum-Störungen. Hogrefe, Göttingen
Holtmann M, Bolte S, Poustka F (2005) ADHD, Asperger syndrome, and high-functioning autism. J Am Acad Child Adolesc Psychiatry 44:1101
Holtmann M, Bolte S, Poustka F (2007) Attention deficit hyperactivity disorder symptoms in pervasive developmental disorders: association with autistic behavior domains and coexisting psychopathology. Psychopathology 40:172–177
Jahromi LB, Kasari CL, Mccracken JT et al (2009) Positive effects of methylphenidate on social communication and self-regulation in children with pervasive developmental disorders and hyperactivity. J Autism Dev Disord 39:395–404
Kochhar P, Batty MJ, Liddle EB et al (2011) Autistic spectrum disorder traits in children with attention deficit hyperactivity disorder. Child Care Health Dev 37:103–110
Konrad K, Eickhoff SB (2010) Is the ADHD brain wired differently? A review on structural and functional connectivity in attention deficit hyperactivity disorder. Hum Brain Mapp 31:904–916
Kuntsi J, Wood AC, Rijsdijk F et al (2010) Separation of cognitive impairments in attention-deficit/hyperactivity disorder into 2 familial factors. Arch Gen Psychiatry 67:1159–1167
Lasky-Su J, Neale BM, Franke B et al (2008) Genome-wide association scan of quantitative traits for attention deficit hyperactivity disorder identifies novel associations and confirms candidate gene associations. Am J Med Genet B Neuropsychiatr Genet 147B:1345–1354
Mahone EM, Powell SK, Loftis CW et al (2006) Motor persistence and inhibition in autism and ADHD. J Int Neuropsychol Soc 12:622–631
Marshall CR, Noor A, Vincent JB et al (2008) Structural variation of chromosomes in autism spectrum disorder. Am J Hum Genet 82:477–488
Minshew NJ, Keller TA (2010) The nature of brain dysfunction in autism: functional brain imaging studies. Curr Opin Neurol 23:124–130
Mulligan A, Anney RJ, O’regan M et al (2009) Autism symptoms in attention-deficit/hyperactivity disorder: a familial trait which correlates with conduct, oppositional defiant, language and motor disorders. J Autism Dev Disord 39:197–209
Neale BM, Lasky-Su J, Anney R et al (2008) Genome-wide association scan of attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 147B:1337–1344
Neale BM, Medland SE, Ripke S et al (2010) Meta-analysis of genome-wide association studies of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 49:884–897
Nijmeijer JS, Arias-Vasquez A, Rommelse NN et al (2010) Identifying loci for the overlap between attention-deficit/hyperactivity disorder and autism spectrum disorder using a genome-wide QTL linkage approach. J Am Acad Child Adolesc Psychiatry 49:675–685
Nijmeijer JS, Hoekstra PJ, Minderaa RB et al (2009) PDD symptoms in ADHD, an independent familial trait? J Abnorm Child Psychol 37:443–453
Nyden A, Gillberg C, Hjelmquist E et al (1999) Executive function/attention deficits in boys with Asperger syndrome, attention disorder and reading/writing disorder. Autism 3:213–228
Ogdie MN, Macphie IL, Minassian SL et al (2003) A genomewide scan for attention-deficit/hyperactivity disorder in an extended sample: suggestive linkage on 17p11. Am J Hum Genet 72:1268–1279
Ozonoff S, Jensen J (1999) Brief report: specific executive function profiles in three neurodevelopmental disorders. J Autism Dev Disord 29:171–177
Poustka L, Poustka F (2007) Psychopharmacology of autistic disorders. Z Kinder Jugendpsychiatr Psychother 35:87–94
Redcay E, Courchesne E (2005) When is the brain enlarged in autism? A meta-analysis of all brain size reports. Biol Psychiatry 58:1–9
Reiersen AM, Constantino JN, Grimmer M et al (2008) Evidence for shared genetic influences on self-reported ADHD and autistic symptoms in young adult Australian twins. Twin Res Hum Genet 11:579–585
Reiersen AM, Constantino JN, Volk HE et al (2007) Autistic traits in a population-based ADHD twin sample. J Child Psychol Psychiatry 48:464–472
Reiersen AM, Todd RD (2008) Co-occurrence of ADHD and autism spectrum disorders: phenomenology and treatment. Expert Rev Neurother 8:657–669
Romanos M, Freitag C, Jacob C et al (2008) Genome-wide linkage analysis of ADHD using high-density SNP arrays: novel loci at 5q13.1 and 14q12. Mol Psychiatry 13:522–530
Rommelse NN, Franke B, Geurts HM et al (2010) Shared heritability of attention-deficit/hyperactivity disorder and autism spectrum disorder. Eur Child Adolesc Psychiatry 19:281–295
Ronald A, Simonoff E, Kuntsi J et al (2008) Evidence for overlapping genetic influences on autistic and ADHD behaviours in a community twin sample. J Child Psychol Psychiatry 49:535–542
Research Units On Pediatric Psychopharmacology Autism Network (2005) Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity. Arch Gen Psychiatry 62:1266–1274
Santosh PJ, Baird G, Pityaratstian N et al (2006) Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study. Child Care Health Dev 32:575–583
Sarimski K, Steinhausen H-C (2007) KIDS – Geistige Behinderung und schwere Entwicklungsstörungen. KIDS Kinder-Diagnostik-System, Bd 2. Hogrefe, Göttingen
Scahill L, Aman MG, Mcdougle CJ et al (2006) A prospective open trial of guanfacine in children with pervasive developmental disorders. J Child Adolesc Psychopharmacol 16:589–598
Simonoff E, Pickles A, Charman T et al (2008) Psychiatric disorders in children with autism spectrum disorders: prevalence, comorbidity, and associated factors in a population-derived sample. J Am Acad Child Adolesc Psychiatry 47:921–929
Sinzig J, Bruning N, Morsch D et al (2007) Age-dependent differences in neuropsychological performance profiles in ADHD and autism. Z Kinder Jugendpsychiatr Psychother 35:95–104, 105–106
Sinzig J, Lehmkuhl G (2007) What do we know about the serotonergic genetic heterogeneity in attention-deficit/hyperactivity and autistic disorders? Psychopathology 40:329–337
Sinzig J, Morsch D, Bruning N et al (2008) Inhibition, flexibility, working memory and planning in autism spectrum disorders with and without comorbid ADHD-symptoms. Child Adolesc Psychiatry Ment Health 2:4
Sinzig J, Morsch D, Lehmkuhl G (2008) Do hyperactivity, impulsivity and inattention have an impact on the ability of facial affect recognition in children with autism and ADHD? Eur Child Adolesc Psychiatry 17:63–72
Smalley SL, Kustanovich V, Minassian SL et al (2002) Genetic linkage of attention-deficit/hyperactivity disorder on chromosome 16p13, in a region implicated in autism. Am J Hum Genet 71:959–963
Sobanski E, Banaschewski T, Asherson P et al (2010) Emotional lability in children and adolescents with attention deficit/hyperactivity disorder (ADHD): clinical correlates and familial prevalence. J Child Psychol Psychiatry 51:915–923
Sowell ER, Thompson PM, Welcome SE et al (2003) Cortical abnormalities in children and adolescents with attention-deficit hyperactivity disorder. Lancet 362:1699–1707
Stanfield AC, Mcintosh AM, Spencer MD et al (2008) Towards a neuroanatomy of autism: a systematic review and meta-analysis of structural magnetic resonance imaging studies. Eur Psychiatry 23:289–299
Szatmari P, Paterson AD, Zwaigenbaum L et al (2007) Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat Genet 39:319–328
Taylor E, Dopfner M, Sergeant J et al (2004) European clinical guidelines for hyperkinetic disorder – first upgrade. Eur Child Adolesc Psychiatry 13(Suppl 1):7–30
Uebel H, Albrecht B, Asherson P et al (2010) Performance variability, impulsivity errors and the impact of incentives as gender-independent endophenotypes for ADHD. J Child Psychol Psychiatry 51:210–218
Wang K, Zhang H, Ma D et al (2009) Common genetic variants on 5p14.1 associate with autism spectrum disorders. Nature 459:528–533
Weiss LA, Shen Y, Korn JM et al (2008) Association between microdeletion and microduplication at 16p11.2 and autism. N Engl J Med 358:667–675
Willcutt EG, Doyle AE, Nigg JT et al (2005) Validity of the executive function theory of attention-deficit/hyperactivity disorder: a meta-analytic review. Biol Psychiatry 57:1336–1346
Williams JG, Higgins JP, Brayne CE (2006) Systematic review of prevalence studies of autism spectrum disorders. Arch Dis Child 91:8–15
Yerys BE, Wallace GL, Sokoloff JL et al (2009) Attention deficit/hyperactivity disorder symptoms moderate cognition and behavior in children with autism spectrum disorders. Autism Res 2:322–333
Zhou K, Dempfle A, Arcos-Burgos M et al (2008) Meta-analysis of genome-wide linkage scans of attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 147:1392–1398
Interessenkonflikte
Der korrespondierende Autor weist auf folgende Beziehungen hin: Prof. M. Holtmann: Mitglied in Advisory Boards von Lilly, Bristol-Myers Squibb, Novartis; Vortragshonorare/Kongressreisen von AstraZeneca, BMS, Janssen-Cilag, Lilly, Medice, Merz, neuroConn, Novartis, Shire; Forschungsförderung von Deutsche Forschungsgemeinschaft DFG und BMBF. Dr. L. Poustka: Vortragshonorare/Kongressreisen von Shire und Lilly. T. Banaschewski: Advisory Board oder Beratungstätigkeit für Bristol Myers-Sqibb, Desitin, Lilly, Medice, Novartis, Pfizer, Shire, UCB und Viforpharma. Reisekosten für Konferenzen oder Vortragshonorare von Lilly, Janssen McNeil, Medice, Novartis, Shire, UCB. Beteiligung an klinischen Studien von Lilly, Shire und Novartis.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Banaschewski, T., Poustka, L. & Holtmann, M. Autismus und ADHS über die Lebensspanne. Nervenarzt 82, 573–581 (2011). https://doi.org/10.1007/s00115-010-3239-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00115-010-3239-6